i-Lumen Scientific™ is a retinal technology company, pioneering a new field of treatment in ophthalmics,

called, "Neural Retinal Therapy”™, designed to improve eyesight in patients whose vision has been impaired by dry age-related macular degeneration (AMD). This new therapy has the potential to address a large unmet patient need in the practice of ophthalmology.

​

i-LUMEN™ has developed patented technology, which utilizes a revolutionary, non-invasive,  

software-based, medical device, to deliver

proprietary pulsed microcurrent stimulation that creates an electrical field, to treat dry AMD.

​

Macular degeneration is a highly debilitating visual disease, with no cure, and no US market-cleared treatment available to improve vision.

Now, with i-Lumen™ technology, there is finally hope for those afflicted with dry AMD.

​